C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation.
about
C1q/TNF-Related Protein-9 Ameliorates Ox-LDL-Induced Endothelial Dysfunction via PGC-1α/AMPK-Mediated Antioxidant Enzyme InductionC1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform.Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosisAssociations of C1q/TNF-Related Protein-9 Levels in Serum and Epicardial Adipose Tissue with Coronary Atherosclerosis in HumansSecreted Frizzled-related Protein 5 Diminishes Cardiac Inflammation and Protects the Heart from Ischemia/Reperfusion Injury.C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss SurgeryObesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.C1q/TNF-Related Protein 9 Protects Diabetic Rat Heart against Ischemia Reperfusion Injury: Role of Endoplasmic Reticulum Stress.Activation of volume-sensitive Cl- channel mediates autophagy-related cell death in myocardial ischaemia/reperfusion injury.High serum C1q-binding adiponectin levels in male patients with acute coronary syndromePlasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients with Type 2 Diabetes without Renal Dysfunction.Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in miceTIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathwayC1q/TNF-related protein 9 inhibits the cholesterol-induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP-dependent kinase.Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?The Role of Inflammation in Cardiovascular Outcome.C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism.Loss of CTRP1 disrupts glucose and lipid homeostasis.AMPK: a novel target for treating hepatic fibrosisC1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease.TAB3 defect induces augmented cardioprotection loss from ischemic injury.The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.Nucleostemin exerts anti-apoptotic function via p53 signaling pathway in cardiomyocytes.C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis.AMPK: Potential Therapeutic Target for Ischemic Stroke
P2860
Q33838323-BF6DFD3D-C794-423A-88A3-381C4806FCDDQ35622442-35F9F279-153C-4B9F-A803-411F7FCF6727Q35846211-9094E27A-27B1-4D8C-A386-EEAE3FBA82ECQ36109426-600C9016-33EB-49AD-864B-35CB8EB9867CQ36548318-0DEE2B6A-7C14-418E-B566-304C9DB6DC70Q36911487-35819794-91B4-4DED-BCFD-4A72585DF044Q36951691-16426C44-A254-46E6-8C15-0C9882064F62Q37076096-ECF1E514-4BC9-4C1E-BF35-9213EFA2F3E0Q37344976-7D6B01E5-28E0-4511-8BBC-C551031E630AQ37457520-EC3BFAFB-5A13-4DBC-8A0F-9EA5AA875E91Q37484895-DAB70635-0591-42C7-8370-8384A0CF4C93Q37539125-5EA2E84B-DF5E-458F-8CA2-6B0BFF8CD6ABQ37656016-5455EFFF-09DC-4CA4-8230-A1F128FE3317Q37713988-FF6C1A7E-9CBA-4A0A-A191-333CD4E85AB0Q38775075-907B8448-E539-4E14-A525-2DD4EF53702CQ38999231-9F608C37-5AE8-4124-9C2C-4BA1AA7B3516Q39134471-AD20492B-863A-41D5-8146-28E0C3C172E2Q40868166-E227FB66-485A-4917-A160-E91EC539E821Q41630446-16FABF0C-5D5A-4546-9C2E-722B28FA6556Q42000401-75EF38B4-0E61-462B-AFDB-B4142D5DD90AQ47697073-D4BE6776-1353-4F6D-9D88-DFC9A17C6E1CQ48141377-EAC575D5-542E-4509-B37C-78B7458E9C1AQ50683753-FAF795A0-B2AB-4D78-9370-40012077D345Q51395640-2C340252-DE3D-4699-881E-01F942C06943Q53442597-BC8792FB-57B1-4B76-951D-A6F5449B75A8Q53511596-F3F48637-E53C-492A-9E27-49859E3AC34DQ55403102-15C44F9C-9392-4AF3-B1CA-80F6399B3858Q57170002-AA20FEF1-64DB-4161-B706-8C903E67C280
P2860
C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
C1q/tumor necrosis factor-rela ...... a protein kinase A activation.
@en
C1q/tumor necrosis factor-rela ...... a protein kinase A activation.
@nl
type
label
C1q/tumor necrosis factor-rela ...... a protein kinase A activation.
@en
C1q/tumor necrosis factor-rela ...... a protein kinase A activation.
@nl
prefLabel
C1q/tumor necrosis factor-rela ...... a protein kinase A activation.
@en
C1q/tumor necrosis factor-rela ...... a protein kinase A activation.
@nl
P2093
P2860
P1433
P1476
C1q/tumor necrosis factor-rela ...... a protein kinase A activation.
@en
P2093
Dinghua Yi
Walter J Koch
Wayne Bond Lau
Xiaoliang Wang
Xiaoming Wang
Xin-Liang Ma
Yajing Wang
Yuexing Yuan
P2860
P304
P356
10.1161/CIRCULATIONAHA.112.000010
P407
P433
11 Suppl 1
P577
2013-09-01T00:00:00Z